Does Wegovy Make Your Muscles Hurt?

What the trial data actually recorded about muscle pain

The STEP 1 trial enrolled 1,961 adults and ran for 68 weeks, making it the most detailed source of side-effect frequency data for semaglutide, the active ingredient in Wegovy, at the 2.4mg dose. Musculoskeletal complaints (covering aching muscles, stiffness and back pain) did appear in the adverse-event tables, but well behind the GI cluster that most people associate with GLP-1 medicines. The NHS patient information for semaglutide lists muscle pain as a possible side effect while noting it affects fewer users than nausea or diarrhoea.

That matters for two reasons. First, it tells you muscle discomfort is real and worth tracking, not imagined or trivial. Second, it tells you the medicine itself is only one possible explanation. When participants lost significant body weight over months, their patterns of movement changed, their calorie intake dropped, and their bodies redistributed load in ways that can independently cause soreness. Separating "Wegovy did this" from "losing weight quickly did this" is genuinely hard, which is why trial data on muscle pain is best read alongside your own clinical picture rather than as a verdict.

If you want to read the detailed side-effect profile that prescribers use, the Wegovy SmPC on the eMC lists frequencies precisely; it is public and worth bookmarking.

Why the weight-loss process itself can make muscles ache

A consistent calorie deficit (the mechanism behind most of Wegovy's effect) reduces the fuel available for muscle repair and recovery. Protein adequacy becomes more important, not less, when appetite falls steeply. Many people on treatment eat considerably less protein than before, not from poor planning but because their hunger signals are so reduced that meals shrink across the board.

Low protein intake over weeks leads to a gradual loss of lean muscle mass, which can show up as generalised aching, fatigue after exercise that previously felt easy, and a sense of heaviness in the legs or shoulders. This is a nutrition issue as much as a pharmacological one. Prescribers routinely recommend prioritising protein at each meal, aiming for adequate daily intake and not letting hydration slip, particularly relevant if GI effects have reduced your fluid intake too.

Exercise patterns shift during treatment as well. Some people become more active as their weight falls; muscles that have been resting under a heavier frame get used differently and can ache in the early weeks. Others scale back if nausea makes movement less appealing. Either change can produce muscle soreness that has little to do with semaglutide's direct action. For a broader look at sore muscles and Wegovy, including what distinguishes mild aching from symptoms worth escalating, that page goes into more detail.

Specific symptoms that need a prescriber's attention

Most muscle discomfort during weight-loss treatment is mild and settles. Some is not. There are patterns worth knowing before you dismiss anything.

Severe stomach pain that spreads toward the back, with or without vomiting, is the urgent signal for pancreatitis, this is not muscle pain in the ordinary sense, but it can be misread as a muscular symptom, and the MHRA has specifically highlighted acute pancreatitis as a known, if infrequent, risk with GLP-1 medicines. If that description fits, seek medical help the same day. Separately, dehydration from persistent vomiting or diarrhoea concentrates in the muscles as cramps and weakness; staying on top of fluids is the first practical step, but if dehydration feels significant, contact your prescriber.

Some people also notice that Wegovy can make their skin hurt, a surface sensitivity quite distinct from deeper muscle or joint discomfort, and understanding the difference helps you describe symptoms more clearly to a clinician. The relationship between Wegovy and joint pain is slightly different again and worth reading if you are unsure whether your discomfort is muscular or articular.

Our prescribers review every repeat order and are reachable for aftercare queries seven days a week, that kind of ongoing clinical contact matters when side effects evolve over a course of treatment. You can read about how we work and the clinical oversight we build into every prescription.

Practical steps that tend to help

None of the following replaces prescriber advice, but they reflect what the evidence consistently points toward for people on GLP-1 treatment who want to protect muscle health.

Protein first. When appetite is suppressed and a meal shrinks to half its former size, protein should be the last thing cut, not the first. Eggs, Greek yoghurt, fish, legumes, the source matters less than the consistency. Alongside that, keeping semaglutide pens stored correctly (refrigerated at 2–8°C; check the patient information leaflet for the exact out-of-fridge window, which varies) and taking the injection on the same day each week reduces the variability in plasma levels that can sometimes amplify side effects during peaks.

Movement matters too. Strength activity, even light resistance work two or three times a week, signals the body to preserve lean tissue during a calorie deficit. The combination of a GLP-1 medicine and strength training is increasingly what the clinical guidance points toward for preserving muscle function, not just reducing weight. For those new to injecting, people often ask whether the Wegovy shot hurts and what to expect from the injection itself, and if you are also curious about whether Wegovy hurts more broadly, including the sensations users commonly report, that page covers the full picture beyond injection-site technique alone.

If discomfort is persistent or you are not sure what you are dealing with, the right step is a conversation with a clinician. Wegovy is a prescription medicine; the clinical relationship does not end at the prescription stage. Those considering treatment for the first time can find an overview of the consultation process at nume, which is open to anyone who wants to understand their options before committing.